Select from the links below:

Publications alphabetically by author:




P-Z

Pao D., Andrady U., Clarke J., Dean G., Drake S., Fisher M., Green T., Kumar S., Murphy M., Tang A., Taylor S., White D., Underhill G., Pillay D. & Cane P.A. (2004). Long term persistence of primary genotypic resistance following HIV-1 seroconversion. Journal of AIDS 37:1570-1573. .

Pao D., Fisher M., Hue S., Dean G., Murphy G., Cane P.A., Sabin C.A., & Pillay, D. (2005). Transmission of HIV-1 during primary infection: relationship to risk and sexually transmitted infections. AIDS 19: 85-90.

Phillips A.N., Dunn D., Sabin C., Pozniak A., Mathias R., Geretti A.M., Clarke J., Churchill D., Williams I., Hill T., Green H., Porter K., Scullard G., Johnson M., Easterbrook P., Gilson R., Fisher M., Loveday C., Gazzard B. & Pillay D. (2005). Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS 19(5):487-494.

Punia P., Cane P.A., Teo C.G., & Saunders N. (2004). Quantitation of hepatitis B lamivudine resistant mutants by real-time amplification refractory mutation system PCR. Journal of Hepatology 40:986-992.

Ramaswamy M., McDonald C., Smith M., Thomas D., Maxwell S., Tenant-Flowers M. & Geretti A.M. (2004). Diagnosis of genital herpes by real-time PCR in routine clinical practice. Sexually Transmitted Infections 80:406-410.

Ramaswamy M., McDonald C., Sabin C., Tenant-Flowers M., Smith M. & Geretti A.M. (2005). The epidemiology of genital infection with herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in genitourinary medicine attendees in inner London. Sexually Transmitted Infections 81:306-308.

Ramaswamy M., Smith M., Thomas D., Maxwell S. & Geretti A.M. (2005). Detection and typing of herpes simplex DNA in genital swabs by real-time polymerase chain reaction. Journal of Virological Methods 126:203-206.

Ramaswamy M., Sabin C., McDonald C., Smith M., Taylor C. & Geretti A.M. (2006). Herpes simplex virus type-2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1 infected persons. Sexually Transmitted Diseases 33(2):96-101.

Rice P., Young Y., Cohen B. & Ramsay M. (2004). MMR immunisation after contact with measles virus. Lancet 363(9408):569-570.

Roest R.W., Carman W.F., Maertzdorf J., Scoular A., Harvey J., Kant M., Van Der Meijden W.I., Verjans Georges M.G.M. & Osterhaus A.D.M.E. (2004). Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. Journal of Medical Virology 73:601-604.

Torre F., Cramp M., Owsianka A., Dornan E., Marsden H., Carman W., Williams R. & Naoumov NV. (2004). Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity. Journal of Medical Virology 72:370-376.

Sabire N., Malone M., Anderson G., Jones A. & Cubitt W.D. (2004). Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. Journal of Clinical Pathology 57:1001-1003.

Sadiq S.T., Fredericks S., Khoo S.H., Rice P. & Holt D.W. (2005). Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance. AIDS. 19(15):1716-1717.

Scott P.D., Ochola R., Ngama M.J., Okiro E.A., Nokes D.J., Medley G.F. & Cane P.A. (2004). Molecular epidemiology of respiratory syncytial virus in Kilifi District, Kenya. Journal of Medical Virology 74:344-354.

Scott P., Arnold E., Evans B., Pozniak A., Moyle G., Shahmanesh M., White D., Shirley J., Cane P. & Pillay D. (2004). Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. Journal of Antimicrobial Chemotherapy 53:469-473.

Scott P.D., Ochola R., Ngama, M., Okiro E.A., Nokes J., Medley G.F., & Cane P.A. (2006). Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya. Journal of Infectious Disease 193:59-67.

Smith M., Geretti A.M., Osner N., Easterbrook P. & Zuckerman M. (2005). High levels of discordance between sequencing and serological subtyping in a predominantly non-B subtype HIV-1 infected cohort. Journal of Clinical Virology 33:312-318.

Stanton R., Westmoreland D., Fox J.D., Davidson A.J., Gavin W. & Wilkinson G. (2005). Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients. Journal of Medical Virology 75:42-46.

Steele A., Al-Chalabi A., Ferrante K., Cudkowitcz M., Brown R.H. & Garson J.A. (2005). Detection of serum reverse transcriptase activity in ALS patients and unaffected blood relatives. Neurology 64:454-458.

Tang J.W., Eames I., Li Y., Taha Y.A., Wilson P., Bellingan G., Ward K.N. & Breuer J. (2005). Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation: the importance of vorticity and buoyancy airflows. Journal of Hospital Infection 61:283-286.

Thomson K.J., Hart D.P., Banerjee L., Ward K.N., Peggs K.S. & Mackinnon S. (2005). The effect of low dose acyclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplantation 35:1065-1069.

Twagira M., Hadzic N., Smith M., Ramaswamy M., Verma A., Dhawan A., Knisely A., Mieli-Vergani G. & Geretti A.M. (2004). Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantation. European Journal of Pediatrics 163:166-169.

van den Hoogen B.G., Herfst S., Sprong L., Cane P., Forleo E., de Swart R., Osterhaus A.D.M.E. & Fouchier, R.A.M. (2004). Antigenic and genetic variability of human met apneumoviruses. Emerging Infectious Diseases 10:658-666.

Vipond I.B., Caul E.O., Hirst D., Carman B., Curry A., Lopman B.A., Read P., Pickett M.A., Lambden P.R. & Clarke I.N. (2004). National epidemic of Lordsdale Norovirus in the UK. Journal of Clinical Virology 30:243-247.

Wallace L.A., Bramley J.C., Ahmed S., Duff R., Hutchison S.J., Carman W.F., Kitchin N.R.E. & Goldberg D.J. (2004). Determinants of universal adolescent hepatitis B vaccine uptake. Archives of Diseases of Childhood 89:1041-1942.

Wallace L.A., Collins T.C., Douglas J.D.M., McIntyre S., Millar J. & Carman W.F. (2004). Virological surveillance of influenza-like illness in the community using PCR and serology. Journal of Clinical Virology 31:40-45.

Ward K.N. (2005). The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infection in the immunocompetent. Journal of Clinical Virology 32:183-193.

Ward K.N. (2005). Human herpesviruses-6 and -7 (HHV-6/7). Current Opinion in Infectious Diseases 18:247-252.

Ward K.N., Andrews N.J., Verity C.M., Miller E. & Ross E.M. (2005). Human herpesviruses-6 & -7 each cause significant neurological morbidity in Britain & Ireland. Archives Disease Childhood 90:619-623.

Ward K.N., Thiruchelvam A.D. & Couto Parada X. (2005). Unexpected occasional persistence of high levels of HHV-6 DNA in sera; detection of variants A and B. Journal of Medical Virology 76:563-570.

White L.J., Waris M., Cane P.A., Nokes D.J., & Medley G.F. (2005). Transmission dynamics of groups A and B human respiratory syncytial virus in England and Wales and Finland: seasonality and cross-protection. Epidemiology & Infection 133:279-289

Winston A., Pozniak A., Mandalia S., Gazzard B., Pillay D. & Nelson M. (2004). Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase. AIDS 18(6):949-951.

Xu L., Pozniak A., Wildfire A., Stanfield-Oakley S.A., Mosier D., Ratcliffe D., Workman J., Joall A., Myers R., Smit E., Cane P.A., Greenberg, M.L. & Pillay D. (2005). Emergence and evolution of resistance to Enfuvirtide following long term therapy involves HR-2 mutations within gp41. Antimicrobial Agents and Chemotherapy 49(3):1113-1119.

Yirrell D.L., Shaw L., Burns S.M., Cameron S.O., Quigg M., Campbell E. & Goldberg D. (2004). HIV-1 subtype in Scotland: the establishment of a national surveillance system. Epidemiology & Infection 132:693-698.




NB. Adobe Acrobat Reader is required to read pdf files.If you don't have a copy
of Adobe Acrobat Reader it can be downloaded by following the link below.





Use the pop up menu below to access a laboratory in your area:




UK CVN Committee Membership

Alternatively you can contact Joy Kean, Scientific Co-ordinator,
UK CVN:

Joy.Kean@ggc.scot.nhs.uk